Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Adelstein

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|July 25, 2003
Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancerMalcolm M DeCamp, Thomas W Rice, David J Adelstein, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 11, 2003
Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinomaThomas W Rice, David J Adelstein, Mark A Chidel, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 16, 2013
Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failureMingsi Li, Robert R Lorenz, Mumtaz J Khan, et al.
Head & Neck|September 11, 2003
Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?Scott A McHam, David J Adelstein, Lisa A Rybicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapyDavid J Adelstein, Jerrold P Saxton, Pierre Lavertu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancerDavid J Adelstein, Yi Li, George L Adams, et al.
Journal of Gastrointestinal Cancer|May 2, 2009
Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancerHeath B Mackley, Jonathan S Adelstein, Chandana A Reddy, et al.
The Annals of Thoracic Surgery|November 28, 2006
Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?Thomas W Rice, Deepak Khuntia, Lisa A Rybicki, et al.
Head & Neck|October 25, 2011
Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderlyStephanie A Michal, David J Adelstein, Lisa A Rybicki, et al.
Head & Neck|December 31, 2013
Solitary dural metastasis at presentation in a patient with untreated human papillomavirus-associated squamous cell carcinoma of the oropharynxSamer Al-Khudari, Susan Guo, Yunwei Chen, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Thoracic and Cardiovascular Surgery|July 25, 2003
Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancerMalcolm M DeCamp, Thomas W Rice, David J Adelstein, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 11, 2003
Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinomaThomas W Rice, David J Adelstein, Mark A Chidel, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 16, 2013
Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failureMingsi Li, Robert R Lorenz, Mumtaz J Khan, et al.
Head & Neck|September 11, 2003
Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?Scott A McHam, David J Adelstein, Lisa A Rybicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapyDavid J Adelstein, Jerrold P Saxton, Pierre Lavertu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancerDavid J Adelstein, Yi Li, George L Adams, et al.
Journal of Gastrointestinal Cancer|May 2, 2009
Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancerHeath B Mackley, Jonathan S Adelstein, Chandana A Reddy, et al.
The Annals of Thoracic Surgery|November 28, 2006
Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?Thomas W Rice, Deepak Khuntia, Lisa A Rybicki, et al.
Head & Neck|October 25, 2011
Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderlyStephanie A Michal, David J Adelstein, Lisa A Rybicki, et al.
Head & Neck|December 31, 2013
Solitary dural metastasis at presentation in a patient with untreated human papillomavirus-associated squamous cell carcinoma of the oropharynxSamer Al-Khudari, Susan Guo, Yunwei Chen, et al.
Pageof 11